Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 2g
Tazobactam 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Parenteral Division of Wyeth Holdings, Carolina, Puerto Rico
Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 4g
Tazobactam 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Parenteral Division of Wyeth Holdings, Carolina, Puerto Rico
Dated this 18th day of October 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).